Strongbridge Biopharma plc - FORM 10-K - EX-23.1 - March 12, 2018

Attached files

file filename
EX-10.21 - EX-10.21 - Strongbridge Biopharma plcsbbp-20171231ex1021db083.htm
10-K - 10-K - Strongbridge Biopharma plcsbbp-20171231x10k.htm
EX-32.1 - EX-32.1 - Strongbridge Biopharma plcsbbp-20171231ex321da51bc.htm
EX-31.2 - EX-31.2 - Strongbridge Biopharma plcsbbp-20171231ex31204923b.htm
EX-31.1 - EX-31.1 - Strongbridge Biopharma plcsbbp-20171231ex31197470e.htm
EX-21.1 - EX-21.1 - Strongbridge Biopharma plcsbbp-20171231ex2119d8b55.htm
EX-10.8 - EX-10.8 - Strongbridge Biopharma plcsbbp-20171231ex108759d9d.htm
EX-10.7 - EX-10.7 - Strongbridge Biopharma plcsbbp-20171231ex107827ecb.htm
EX-10.30 - EX-10.30 - Strongbridge Biopharma plcsbbp-20171231ex103082087.htm
EX-10.29 - EX-10.29 - Strongbridge Biopharma plcsbbp-20171231ex1029f5b7c.htm
EX-10.28 - EX-10.28 - Strongbridge Biopharma plcsbbp-20171231ex1028922e7.htm
EX-10.20 - EX-10.20 - Strongbridge Biopharma plcsbbp-20171231ex1020df7ca.htm
EX-10.2 - EX-10.2 - Strongbridge Biopharma plcsbbp-20171231ex10220bb80.htm
EX-10.19 - EX-10.19 - Strongbridge Biopharma plcsbbp-20171231ex101964a36.htm
EX-10.18 - EX-10.18 - Strongbridge Biopharma plcsbbp-20171231ex1018f0f4a.htm
EX-10.17 - EX-10.17 - Strongbridge Biopharma plcsbbp-20171231ex1017db93b.htm
EX-10.16 - EX-10.16 - Strongbridge Biopharma plcsbbp-20171231ex1016b1975.htm
EX-10.15 - EX-10.15 - Strongbridge Biopharma plcsbbp-20171231ex101561d17.htm
EX-10.14 - EX-10.14 - Strongbridge Biopharma plcsbbp-20171231ex1014f0f8a.htm
EX-10.13 - EX-10.13 - Strongbridge Biopharma plcsbbp-20171231ex1013697ef.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-222818, 333-215532)  of our report dated March 12, 2018, with respect to the consolidated financial statements of Strongbridge Biopharma plc included in this Annual Report (Form 10-K) for the year ended December 31, 2017.

/s/ Ernst & Young LLP

Philadelphia, Pennsylvania
March 12, 2018

 

Strongbridge Biopharma plc Reports